Table 16.
Methylated arginine according to melanoma stage.
| Parameters | Melanoma Stage | ||||||
|---|---|---|---|---|---|---|---|
| I | II | III | IV | ||||
| SDMA (μmol/L) | 0.90 ± 0.07 | 0.93 ± 0.05 | p1 < 0.05 | 0.97 ± 0.04 |
p1 < 0.05 p2 < 0.05 |
1.02 ± 0.07 |
p1 < 0.05 p2 < 0.05 p3 < 0.05 |
| ADMA (μmol/L) | 0.77 ± 0.06 | 0.83 ± 0.08 | p1 < 0.05 | 0.91 ± 0.10 |
p1 < 0.05 p2 < 0.05 |
0.95 ± 0.12 |
p1 < 0.05 p2 < 0.05 p3 < 0.05 |
| ADMA/SDMA | 0.88 ± 0.05 | 0.88 ± 0.07 | p1 > 0.05 | 0.93 ± 0.09 |
p1 > 0.05 p2 > 0.05 |
0.89 ± 0.09 |
p1 > 0.05 p2 > 0.05 p3 < 0.05 |
SDMA = symmetric dimethylarginine; ADMA = asymmetric dimethylarginine; p1 = melanoma stages II, III, and IV vs. I; p2 = melanoma stages III and IV vs. II; p3 = melanoma stage IV vs. III.